Development of new neuroprotective treatments for glaucoma
| Project/Area Number |
22791656
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
IKEDA Hanako 京都大学, 医学研究科, 助教 (20372162)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | 眼科 / 緑内障 / 治療 / 神経保護 |
|---|
| Research Abstract |
Glaucoma, the most major cause of vision loss in Japan, is characterized by progressive visual field loss due to loss of retinal ganglion cells. Inhibitors for VCP has been elucidated to have neuroprotective effect and to delay disease progression on mouse models of glaucoma. They might be new neuroprotective drugs for glaucoma patients.
|
Report
(3 results)
Research Products
(12 results)
